Delivery Order SPE2DB20D3103-SPE2DB22FM6H7

Award Date 2/9/22
Potential Completion Date 2/10/22
Potential Value $15K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Menactra vaccine vials to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $14,290.40, was issued to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
This federal contract award, with a ceiling value of $7,145.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order without a set-aside designation, indicating open competition. It covers the provision of the MENACTRA VIAL 0.5ML vaccine product, with a period of performance through August 25, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $64,875.60 firm-fixed-price delivery order is for the procurement of Menactra vaccine vials. The contract has an ultimate completion date of March 4, 2022 and was awarded on March 3, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of pharmaceutical...
This federal contract award, valued at $124,292.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Menactra vaccine vials, a critical medical product for infectious disease prevention. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
This federal contract award, valued at $237,750.18, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of MENACTRA VIAL 0.5ML, a vaccine product, with a completion date of November 19, 2015. This contract is a Firm Fixed Price Delivery Order, and there was no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is for the delivery of pharmaceutical products, including Menactra vaccine vials, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award has a ceiling value of $142,904.00 and is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with...
This federal contract award is for the delivery of Menactra vaccine vials to the Defense Logistics Agency (DLA). The award, with a ceiling value of $85,482.40, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an existing Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $230,032.94 firm fixed-price delivery order is for the delivery of the MENACTRA VIAL 0.5ML vaccine product. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the primary...
This federal contract award to Amerisourcebergen Drug Corp, a division of Cencora, Inc., is a delivery order valued at $32,565.33 for the supply of Menactra vaccine vials. The award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense, and does not have a set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $100,422.00 firm fixed price contract is for the supply of MENACTRA VIAL 0.5ML, a vaccine product. The contract has an ultimate completion date of June 9, 2015. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB22FM6H7
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of MENACTRA VIAL 0.5ML, a vaccine product. The contract is a Delivery Order with a Firm Fixed Price valued at $15,247.60 and has a completion date of February 10, 2022.

Amerisourcebergen is the prime contractor for this award, which is associated with a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between Cencora, Inc. (Amerisourcebergen's parent company) and the DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities and Department of Veterans Affairs healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 10:01 AM